Clinical Trial Update: Safety and Efficacy of GS-4774 for the Treatment of Chronic Hepatitis B [Phase 2]

View source ↗

Summary

Phase 2 trial update on GS-4774 for chronic hepatitis B reports safety and efficacy results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• GS-4774 (GI-13020)

Snippet

Sponsor: Gilead Sciences | Conditions: Chronic HBV Infection | Phase 2 | Status: COMPLETED | Results posted: 2019-11-01